Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Shenzhen Neptunus Bioengineering Co stock

000078.SZ
CNE000000X95

Price

2.96
Today +/-
-0.01
Today %
-2.01 %
P

Shenzhen Neptunus Bioengineering Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Shenzhen Neptunus Bioengineering Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Shenzhen Neptunus Bioengineering Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Shenzhen Neptunus Bioengineering Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Shenzhen Neptunus Bioengineering Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Shenzhen Neptunus Bioengineering Co Stock Price History

DateShenzhen Neptunus Bioengineering Co Price
11/8/20242.96 undefined
11/7/20243.02 undefined
11/6/20242.84 undefined
11/5/20242.79 undefined
11/4/20242.73 undefined
11/1/20242.70 undefined
10/31/20242.78 undefined
10/30/20242.65 undefined
10/29/20242.64 undefined
10/28/20242.75 undefined
10/25/20242.68 undefined
10/24/20242.54 undefined
10/23/20242.50 undefined
10/22/20242.50 undefined
10/21/20242.44 undefined
10/18/20242.45 undefined
10/17/20242.40 undefined
10/16/20242.45 undefined
10/15/20242.43 undefined
10/14/20242.49 undefined
10/11/20242.38 undefined

Shenzhen Neptunus Bioengineering Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shenzhen Neptunus Bioengineering Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shenzhen Neptunus Bioengineering Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shenzhen Neptunus Bioengineering Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shenzhen Neptunus Bioengineering Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shenzhen Neptunus Bioengineering Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shenzhen Neptunus Bioengineering Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shenzhen Neptunus Bioengineering Co’s growth potential.

Shenzhen Neptunus Bioengineering Co Revenue, EBIT and net profit per share

DateShenzhen Neptunus Bioengineering Co RevenueShenzhen Neptunus Bioengineering Co EBITShenzhen Neptunus Bioengineering Co Net Income
202336.42 B undefined353.64 M undefined-1.69 B undefined
202237.83 B undefined608.77 M undefined-1.03 B undefined
202141.05 B undefined1.46 B undefined93.3 M undefined
202040.02 B undefined1.7 B undefined-289 M undefined
201941.49 B undefined2.18 B undefined206 M undefined
201838.38 B undefined1.97 B undefined415 M undefined
201724.94 B undefined1.57 B undefined636 M undefined
201613.61 B undefined795 M undefined418 M undefined
201511.12 B undefined447 M undefined475 M undefined
20149.8 B undefined267 M undefined24 M undefined
20137.99 B undefined224 M undefined117 M undefined
20126.42 B undefined215 M undefined59 M undefined
20115.29 B undefined189 M undefined38 M undefined
20104 B undefined152 M undefined47 M undefined
20092.71 B undefined32 M undefined14 M undefined
20082.26 B undefined-49 M undefined-13 M undefined
20072.5 B undefined52 M undefined33 M undefined
20062.7 B undefined-18 M undefined29 M undefined
20052.66 B undefined-430 M undefined-742 M undefined
20042.32 B undefined124 M undefined22 M undefined

Shenzhen Neptunus Bioengineering Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (B)DOCUMENTS
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.060.090.20.770.831.462.322.662.72.52.262.7145.296.427.999.811.1213.6124.9438.3841.4940.0241.0537.8336.42
-37.50126.14284.428.3775.7559.3714.471.47-7.49-9.6220.1847.5632.3121.3024.5422.6313.4322.3883.3053.898.11-3.552.58-7.84-3.74
73.4477.2778.3968.6371.5336.2420.209.1013.2413.9115.8316.9016.1816.0115.0815.0414.4914.6214.8614.3713.1113.2611.5910.709.989.66
0.050.070.160.530.590.530.470.240.360.350.360.460.650.850.971.21.421.632.023.585.035.54.644.393.783.52
0.030.030.10.140.10.10.12-0.43-0.020.05-0.050.030.150.190.220.220.270.450.81.571.972.181.71.460.610.35
39.0636.3651.7617.6511.587.075.34-16.18-0.672.08-2.171.183.803.573.352.802.724.025.846.305.145.254.243.551.610.97
24315470421022-7422933-131447385911724475418636415206-28993-1,027-1,689
-29.1774.1929.63-40.00-76.19120.00-3,472.73-103.9113.79-139.39-207.69235.71-19.1555.2698.31-79.491,879.17-12.0052.15-34.75-50.36-240.29-132.18-1,204.3064.46
0.790.530.530.761.141.141.141.141.631.631.631.631.631.631.631.781.831.842.232.622.652.652.622.752.752.75
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Shenzhen Neptunus Bioengineering Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Shenzhen Neptunus Bioengineering Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
0.060.040.11.231.221.441.021.270.710.510.390.470.90.821.091.51.533.083.073.211.281.391.731.021.561.55
0.040.10.150.260.470.770.630.50.580.570.450.70.981.742.163.224.145.377.2114.0118.9518.0516.7318.9918.8117.36
0.040.040.060.340.390.190.330.350.490.570.550.320.50.540.60.790.991.442.213.414.525.526.223.933.513.37
0.010.020.030.060.070.240.310.330.320.250.250.330.490.660.710.8611.071.493.333.953.723.913.794.193.68
00.0100.170.220.190.490.510.340.220.160.10.090.120.180.260.280.220.341.044.95.895.043.883.452.85
0.140.210.342.062.362.832.782.952.442.11.821.922.963.874.736.637.9311.1714.312533.634.5733.6331.6231.5228.81
0.040.210.230.370.40.460.610.720.690.650.740.450.420.450.570.640.870.550.60.911.031.121.191.481.381.28
0.030.030.20.510.460.60.170.170.130.110.080.520.50.210.190.310.330.260.430.630.670.740.71.230.610.53
0000000000000000004101112374534.1714.643.71
151821884209134161146193155174174188210244309315333366399345396401532.35518.45472.13
000000000.030.030.030.030.030.030.030.040.040.10.483.553.923.332.472.331.750.86
00.010000.010.0100.070.060.060.080.050.070.110.090.150.350.470.271.450.971.290.390.460.35
0.090.440.450.971.071.20.951.041.1111.091.251.190.971.141.391.71.592.355.867.526.66.095.994.733.5
0.230.640.793.033.434.033.733.993.543.12.93.164.154.845.868.029.6312.7616.6630.8641.1341.1739.7237.636.2532.3
                                                   
0.080.150.150.220.330.330.330.330.480.620.650.650.650.650.650.730.730.752.652.652.652.762.752.752.752.75
0.080.020.021.381.271.271.241.271.131.021.161.011.071.071.061.551.441.472.662.312.332.562.472.322.222.24
0.020.04-0.010.060.10.04-0.17-0.91-0.93-0.9-1.04-1.03-0.98-0.93-0.87-0.75-0.73-0.250.160.621.031.230.941.040.01-1.68
000-10,000-18,000-2,000-5,000-3,0000000000-4,000-1,00000001,000-5,000000
00000000000000000000000-10.95-19.37-36.8
0.170.20.161.661.691.641.40.690.680.740.770.630.740.790.841.521.441.975.475.5766.566.166.14.973.28
00.010.010.030.080.220.190.550.590.470.430.640.861.321.552.072.573.134.036.787.517.948.297.767.917.6
13212141162867555949508388115234364403436542.15660.85664.63
0.020.170.050.110.150.120.320.170.240.120.380.280.290.360.380.60.891.240.884.785.724.233.543.193.392.4
0.030.250.560.911.111.991.762.331.681.491.031.381.962.162.823.44.245.975.5910.8716.0417.4419.561817.6316.82
0000000.010.1100.010.010.050.0600000000.951.810.060.270.10.24
0.050.430.621.061.352.352.273.182.522.091.862.353.183.864.86.127.7810.4310.6222.6630.5931.8331.8729.7629.6927.73
00000.020.01000.130.120.20.120.06000000.021.73.371.360.160.380.410.32
00000000114000000000003216.0814.3513.15
000002314011328514691851403947128196136.8726.7923.11
00000.020.01000.180.130.210.130.060.010.010.010.070.190.161.743.421.490.360.530.450.36
0.050.440.621.061.372.362.283.182.72.222.062.473.243.864.816.137.8510.6210.7824.434.0133.3232.2330.330.1428.09
0.230.640.782.723.0643.673.873.382.962.833.13.994.665.657.659.2912.5916.2629.9740.0139.8838.3936.3935.1131.37
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Shenzhen Neptunus Bioengineering Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Shenzhen Neptunus Bioengineering Co's financial health and stability.

Assets

Shenzhen Neptunus Bioengineering Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Shenzhen Neptunus Bioengineering Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Shenzhen Neptunus Bioengineering Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Shenzhen Neptunus Bioengineering Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
0000000000000000000000000
0000000000000000000000000
0000000000000000000000000
-73-59-170-232-376-300-242-165-70-312-185-156-259-385-540-974-1,031-531-1,718-1,347-1,603-2,357-1,553-2,395-2,389
0000000000000000000000000
0000000000000000000000000
-10-9-31-99-135-92-114-95-60-71-84-114-149-194-239-278-345-389-512-889-1,451-1,345-1,074-1,101-931
-0.04-0.02-0.11-0.08-0.11-0.04-0.060.040.050.050.210.210.04-0.19-0.08-0.12-0.120.09-1.5-2.43-1.142.271.650.87-0.06
-6-30-38-190-52-123-143-189-148-96-62-130-111-100-159-285-236-170-283-272-213-167-147-129-94
-2-80-103-368-82-244-87-1811394624-265-99167-158-191-273-89-732-1,431-1,747-327-231-609-275
3-50-65-178-29-12056828714286-13512267194-3681-449-1,159-1,533-159-83-479-180
0000000000000000000000000
0.010.090.30.20.220.540.070.12-0.25-0.34-0.230.540.450.060.620.120.41-0.04-0.555.293.20.01-0.22-1.78-0
99000000000000000000000000
0.090.080.281.540.04-0.17-0.170.18-0.33-0.16-0.250.130.30.130.430.590.160.692.453.992.34-1.84-1.31-0.770.32
0-0.0101.39-0.13-0.66-0.190.150.020.280.07-0.34-0.040.2-0.050.63-0.031.013.19-1.130.31-0.51-0.311.570.97
-15-3-27-49-50-54-47-91-90-102-95-76-102-118-139-161-217-284-199-171-1,162-1,340-771-565-648
0.10.030.161.340.25-0.1-0.020.330.050.370.460.550.690.50.891.41.031.70.95-0.071.386.074.393.853.24
-44.3-50.1-147.3-272.8-164.7-160.2-204.7-153.6-94.2-45.8146.976.3-70-290.4-241.5-408.9-354.1-79.8-1,780.1-2,705.4-1,348.72,101.11,503.3736.89-158.65
0000000000000000000000000

Shenzhen Neptunus Bioengineering Co stock margins

The Shenzhen Neptunus Bioengineering Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shenzhen Neptunus Bioengineering Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shenzhen Neptunus Bioengineering Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shenzhen Neptunus Bioengineering Co's sales revenue. A higher gross margin percentage indicates that the Shenzhen Neptunus Bioengineering Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shenzhen Neptunus Bioengineering Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shenzhen Neptunus Bioengineering Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shenzhen Neptunus Bioengineering Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shenzhen Neptunus Bioengineering Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shenzhen Neptunus Bioengineering Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shenzhen Neptunus Bioengineering Co Margin History

Shenzhen Neptunus Bioengineering Co Gross marginShenzhen Neptunus Bioengineering Co Profit marginShenzhen Neptunus Bioengineering Co EBIT marginShenzhen Neptunus Bioengineering Co Profit margin
20239.66 %0.97 %-4.64 %
20229.98 %1.61 %-2.72 %
202110.7 %3.55 %0.23 %
202011.59 %4.24 %-0.72 %
201913.26 %5.25 %0.5 %
201813.11 %5.14 %1.08 %
201714.37 %6.3 %2.55 %
201614.86 %5.84 %3.07 %
201514.62 %4.02 %4.27 %
201414.49 %2.72 %0.24 %
201315.04 %2.8 %1.46 %
201215.08 %3.35 %0.92 %
201116.01 %3.57 %0.72 %
201016.18 %3.8 %1.18 %
200916.9 %1.18 %0.52 %
200815.83 %-2.17 %-0.58 %
200713.91 %2.08 %1.32 %
200613.24 %-0.67 %1.08 %
20059.1 %-16.18 %-27.92 %
200420.2 %5.34 %0.95 %

Shenzhen Neptunus Bioengineering Co Stock Sales Revenue, EBIT, Earnings per Share

The Shenzhen Neptunus Bioengineering Co earnings per share therefore indicates how much revenue Shenzhen Neptunus Bioengineering Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shenzhen Neptunus Bioengineering Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shenzhen Neptunus Bioengineering Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shenzhen Neptunus Bioengineering Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shenzhen Neptunus Bioengineering Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shenzhen Neptunus Bioengineering Co Revenue, EBIT and net profit per share

DateShenzhen Neptunus Bioengineering Co Sales per ShareShenzhen Neptunus Bioengineering Co EBIT per shareShenzhen Neptunus Bioengineering Co Earnings per Share
202313.24 undefined0.13 undefined-0.61 undefined
202213.75 undefined0.22 undefined-0.37 undefined
202114.92 undefined0.53 undefined0.03 undefined
202015.26 undefined0.65 undefined-0.11 undefined
201915.68 undefined0.82 undefined0.08 undefined
201814.5 undefined0.75 undefined0.16 undefined
20179.51 undefined0.6 undefined0.24 undefined
20166.1 undefined0.36 undefined0.19 undefined
20156.06 undefined0.24 undefined0.26 undefined
20145.36 undefined0.15 undefined0.01 undefined
20134.49 undefined0.13 undefined0.07 undefined
20123.94 undefined0.13 undefined0.04 undefined
20113.24 undefined0.12 undefined0.02 undefined
20102.45 undefined0.09 undefined0.03 undefined
20091.66 undefined0.02 undefined0.01 undefined
20081.38 undefined-0.03 undefined-0.01 undefined
20071.53 undefined0.03 undefined0.02 undefined
20061.65 undefined-0.01 undefined0.02 undefined
20052.33 undefined-0.38 undefined-0.65 undefined
20042.03 undefined0.11 undefined0.02 undefined

Shenzhen Neptunus Bioengineering Co business model

Shenzhen Neptunus Bioengineering Co is one of the most popular companies on Eulerpool.com.

Shenzhen Neptunus Bioengineering Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Shenzhen Neptunus Bioengineering Co historical P/E ratio, EBIT multiple, and P/S ratio

Shenzhen Neptunus Bioengineering Co shares outstanding

The number of shares was Shenzhen Neptunus Bioengineering Co in 2023 — This indicates how many shares 2.751 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Shenzhen Neptunus Bioengineering Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Shenzhen Neptunus Bioengineering Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Shenzhen Neptunus Bioengineering Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Shenzhen Neptunus Bioengineering Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Shenzhen Neptunus Bioengineering Co stock splits

In Shenzhen Neptunus Bioengineering Co's history, there have been no stock splits.

Shenzhen Neptunus Bioengineering Co dividend history and estimates

In 2023, Shenzhen Neptunus Bioengineering Co paid a dividend amounting to 0 CNY. Dividend means that Shenzhen Neptunus Bioengineering Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Shenzhen Neptunus Bioengineering Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Shenzhen Neptunus Bioengineering Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Shenzhen Neptunus Bioengineering Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Shenzhen Neptunus Bioengineering Co Dividend History

DateShenzhen Neptunus Bioengineering Co Dividend
20190.02 undefined
20180.07 undefined

Shenzhen Neptunus Bioengineering Co dividend payout ratio

In 2023, Shenzhen Neptunus Bioengineering Co had a payout ratio of 33.33%. The payout ratio indicates the percentage of the company's profits that Shenzhen Neptunus Bioengineering Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Shenzhen Neptunus Bioengineering Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Shenzhen Neptunus Bioengineering Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Shenzhen Neptunus Bioengineering Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Shenzhen Neptunus Bioengineering Co Payout Ratio History

DateShenzhen Neptunus Bioengineering Co Payout ratio
202333.33 %
202231.25 %
202134.38 %
202034.38 %
201925 %
201843.75 %
201734.38 %
201634.38 %
201534.38 %
201434.38 %
201334.38 %
201234.38 %
201134.38 %
201034.38 %
200934.38 %
200834.38 %
200734.38 %
200634.38 %
200534.38 %
200434.38 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Shenzhen Neptunus Bioengineering Co.

Shenzhen Neptunus Bioengineering Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20140.05 -0.02  (-131.24 %)2014 Q4
9/30/20140.03 0  (-97.52 %)2014 Q3
6/30/20140.02 0.01  (-40.5 %)2014 Q2
12/31/20130.01 0.03  (304.94 %)2013 Q4
9/30/20130 0  (0 %)2013 Q3
6/30/20130.01 0.01  (121.54 %)2013 Q2
12/31/20120.02 -0  (-101.71 %)2012 Q4
9/30/20120.01 0.01  (-50.44 %)2012 Q3
6/30/20120.02 0.02  (1.23 %)2012 Q2
12/31/20110.01 0  (-90.98 %)2011 Q4
1
2

Eulerpool ESG Scorecard© for the Shenzhen Neptunus Bioengineering Co stock

Eulerpool World ESG Rating (EESG©)

20/ 100

🌱 Environment

30

👫 Social

12

🏛️ Governance

19

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Shenzhen Neptunus Bioengineering Co shareholders

%
Name
Stocks
Change
Date
46.23298 % Shenzhen Neptunus Group Co., Ltd.1,216,445,12806/30/2024
0.76374 % Kong (Xianjun)20,095,00095,0006/30/2024
0.68985 % Guo (Fengming)18,150,70013,388,3006/30/2024
0.32708 % Zhang (Hua)8,605,94006/30/2024
0.25845 % Shi (Xiaoming)6,800,02706/30/2024
0.22044 % Sun (Yinsuo)5,800,05006/30/2024
0.21349 % The Vanguard Group, Inc.5,617,25009/30/2024
0.21205 % Liu (Tuo)5,579,2005,579,2006/30/2024
0.19026 % Huang (Chubin)5,006,00006/30/2024
0.19003 % Liu (Zhanjun)5,000,00006/30/2024
1
2
3
4
5
...
6

Shenzhen Neptunus Bioengineering Co Executives and Management Board

Mr. Feng Zhang(51)
Shenzhen Neptunus Bioengineering Co President, Vice Chairman of the Board
Compensation 4.24 M
Mr. Dakai Shen(58)
Shenzhen Neptunus Bioengineering Co Chief Financial Officer, Vice President, Director (since 2006)
Compensation 1.99 M
Mr. Yifei Zhang(50)
Shenzhen Neptunus Bioengineering Co Executive Vice President, Director (since 2010)
Compensation 1.38 M
Mr. Xiaopeng Zhang(52)
Shenzhen Neptunus Bioengineering Co Vice President
Compensation 1.16 M
Mr. Shuancheng Yang(59)
Shenzhen Neptunus Bioengineering Co Vice President
Compensation 1.13 M
1
2
3
4

Shenzhen Neptunus Bioengineering Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Shenzhen Neptunus H Stock
Shenzhen Neptunus H
SupplierCustomer0,520,550,22-0,29-0,490,51
Shandong Wohua Pharm Stock
Shandong Wohua Pharm
SupplierCustomer0,400,920,550,300,270,87
Xinlun New Materials A Stock
Xinlun New Materials A
SupplierCustomer-0,210,480,16-0,48-0,54-0,01
1

Most common questions regarding Shenzhen Neptunus Bioengineering Co

What is the P/E ratio of Shenzhen Neptunus Bioengineering Co 2024?

The P/E ratio cannot be calculated for Shenzhen Neptunus Bioengineering Co at the moment.

What is the P/S ratio of Shenzhen Neptunus Bioengineering Co 2024?

The P/S cannot be calculated for Shenzhen Neptunus Bioengineering Co currently.

What is the Quality Investing of Shenzhen Neptunus Bioengineering Co?

The Quality Investing for Shenzhen Neptunus Bioengineering Co is 2/10.

What is the revenue of Shenzhen Neptunus Bioengineering Co 2024?

The revenue cannot currently be calculated for Shenzhen Neptunus Bioengineering Co.

How high is the profit of Shenzhen Neptunus Bioengineering Co 2024?

The profit cannot currently be calculated for Shenzhen Neptunus Bioengineering Co.

What is the business model of Shenzhen Neptunus Bioengineering Co

No history available for Shenzhen Neptunus Bioengineering Co.

What is the Shenzhen Neptunus Bioengineering Co dividend?

Shenzhen Neptunus Bioengineering Co pays a dividend of 0 CNY distributed over payouts per year.

How often does Shenzhen Neptunus Bioengineering Co pay dividends?

The dividend cannot currently be calculated for Shenzhen Neptunus Bioengineering Co or the company does not pay out a dividend.

What is the Shenzhen Neptunus Bioengineering Co ISIN?

The ISIN of Shenzhen Neptunus Bioengineering Co is CNE000000X95.

What is the Shenzhen Neptunus Bioengineering Co ticker?

The ticker of Shenzhen Neptunus Bioengineering Co is 000078.SZ.

How much dividend does Shenzhen Neptunus Bioengineering Co pay?

Over the past 12 months, Shenzhen Neptunus Bioengineering Co paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 0.68 %. For the coming 12 months, Shenzhen Neptunus Bioengineering Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Shenzhen Neptunus Bioengineering Co?

The current dividend yield of Shenzhen Neptunus Bioengineering Co is 0.68 %.

When does Shenzhen Neptunus Bioengineering Co pay dividends?

Shenzhen Neptunus Bioengineering Co pays a quarterly dividend. This is distributed in the months of May, July, March, August.

How secure is the dividend of Shenzhen Neptunus Bioengineering Co?

Shenzhen Neptunus Bioengineering Co paid dividends every year for the past 0 years.

What is the dividend of Shenzhen Neptunus Bioengineering Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Shenzhen Neptunus Bioengineering Co located?

Shenzhen Neptunus Bioengineering Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shenzhen Neptunus Bioengineering Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shenzhen Neptunus Bioengineering Co from 7/16/2019 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 7/16/2019.

When did Shenzhen Neptunus Bioengineering Co pay the last dividend?

The last dividend was paid out on 7/16/2019.

What was the dividend of Shenzhen Neptunus Bioengineering Co in the year 2023?

In the year 2023, Shenzhen Neptunus Bioengineering Co distributed 0 CNY as dividends.

In which currency does Shenzhen Neptunus Bioengineering Co pay out the dividend?

The dividends of Shenzhen Neptunus Bioengineering Co are distributed in CNY.

All fundamentals about Shenzhen Neptunus Bioengineering Co

Our stock analysis for Shenzhen Neptunus Bioengineering Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shenzhen Neptunus Bioengineering Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.